| Identification | More |  [Name]
  DL-2,3-DIAMINOPROPIONIC ACID MONOHYDROCHLORIDE |  [CAS]
  54897-59-5 |  [Synonyms]
  2,3-DIAMINOPROPIONIC ACID MONOHYDROCHLORIDE 3-AMINO-DL-ALANINE HYDROCHLORIDE 3-AMINO-DL-ALANINE MONOHYDROCHLORIDE DL-2,3-DIAMINOPROPIONIC ACID HYDROCHLORIDE DL-2,3-DIAMINOPROPIONIC ACID MONOHYDROCHLORIDE DL-3-AMINOALANINE HYDROCHLORIDE DL-ALPHA-BETA-DIAMINOPROPIONIC ACID HYDROCHLORIDE 3-amino-dl-alaninmonohydrochloride (+-)-2,3-diaminopropionic acid hydrochloride DL-2-3-DIAMINOPROPIONIC ACIDMONOHYDROCHL ORIDE CRYS Dl-2,3-DiaminopropionicAcid99% DL-2,3-Diaminopropionic Acid HCl Alanine, 3-amino-, monohydrochloride h-dl-dap-oh.hcl DL-2,3-Diaminopropionic acid hydrochloride, HPLC 98% (±)-3-Aminoalanine monohydrochloride rac-(2R*)-2,3-Diaminopropionic acid·hydrochloride |  [EINECS(EC#)]
  259-387-1 |  [Molecular Formula]
  C3H9ClN2O2 |  [MDL Number]
  MFCD00012884 |  [Molecular Weight]
  140.57 |  [MOL File]
  54897-59-5.mol |  
 | Chemical Properties | Back Directory |  [Appearance]
  white to slightly beige fine crystalline powder |  [Melting point ]
  231-233 °C (dec.) |  [storage temp. ]
  0-6°C |  [solubility ]
  Soluble in DMSO |  [form ]
  Fine Crystalline Powder |  [color ]
  White to slightly beige |  [Water Solubility ]
  almost transparency |  [Merck ]
  14,2984 |  [BRN ]
  5293359 |  [InChIKey]
  SKWCZPYWFRTSDD-UHFFFAOYSA-N |  [CAS DataBase Reference]
  54897-59-5(CAS DataBase Reference) |  
 | Safety Data | Back Directory |  [Hazard Codes ]
  Xi |  [Risk Statements ]
  R36/37/38:Irritating to eyes, respiratory system and skin . |  [Safety Statements ]
  S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . S36:Wear suitable protective clothing . S37/39:Wear suitable gloves and eye/face protection . |  [WGK Germany ]
  3 
 |  [F ]
  3-10 |  [HS Code ]
  29224999 |  
 | Hazard Information | Back Directory |  [Chemical Properties]
  white to slightly beige fine crystalline powder |  [Uses]
  Dl-2,3-Diaminopropionic Acid, Hydrochloride can be used for pharmaceutical composition for viral infections. |  [reaction suitability]
  reaction type: solution phase peptide synthesis |  
  
             | 
            
            
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
             |